INS and diabetes mellitus: HbA1c, FPG, and total daily insulin doses decreased significantly after combination therapy with TZD and insulin in patients with type 2 diabetes mellitus, suggesting that the insulin-sensitizing characteristics of TZDs are likely more pronounced in patients who are not totally devoid of endogenous insulin secretion.